Lower doses venlafaxine-associated toxic hepatitis in a patient with chronic hepatitis
Küçük Resim Yok
Tarih
2003
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Toxic hepatitis is observed with high doses of Venlafaxine. But toxic hepatitis has not been yet reported at tower doses of Venlafaxine such as 37.5 mg per day. In this case report, a case of Venlafaxine-associated toxic hepatitis with tower doses in patient with history of chronic hepatitis is presented. We suggest that liver function should be regularly monitored in patients with history of chronic hepatitis receiving Ventafaxine even at tower doses and even when their liver enzymes are normal.
Açıklama
Anahtar Kelimeler
Chronic Hepatitis, Toxic Hepatitis, Ventafaxine
Kaynak
Pakistan Journal of Medical Sciences
WoS Q Değeri
Scopus Q Değeri
Q3
Cilt
19
Sayı
3
